Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol-Reference-Cited by-同舟云学术

Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol

Published:2015-11-19 Issue:1 Volume:4 Page:
ISSN:2193-1801
Container-title:SpringerPlus
language:en
Short-container-title:SpringerPlus

Author:

Arabi Yaseen,Balkhy Hanan,Hajeer Ali H.,Bouchama Abderrezak,Hayden Frederick G.,Al-Omari Awad,Al-Hameed Fahad M.,Taha Yusri,Shindo Nahoko,Whitehead John,Merson Laura,AlJohani Sameera,Al-Khairy Khalid,Carson Gail,Luke Thomas C.,Hensley Lisa,Al-Dawood Abdulaziz,Al-Qahtani Saad,Modjarrad Kayvon,Sadat Musharaf,Rohde Gernot,Leport Catherine,Fowler Robert

Funder

King Abdullah International Medical Research Center, Riyadh, Saudi Arabia

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://link.springer.com/content/pdf/10.1186/s40064-015-1490-9.pdf

Reference15 articles.

1. Cheng Y, Wong R, Soo YO et al (2005) Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis 24:44–46

2. Clopper CJ, Pearson ES (1934) the use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 26:404–413

3. Drosten C, Meyer B, Muller MA et al (2014) Transmission of MERS-coronavirus in household contacts. N Engl J Med 371:828–835